Technical information
Manufacturer
Laboratoires PROSTRAKAN PHARMA
Presentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
EdcLH4VkLt2dfkhK